Faeth Therapeutics, Inc. (SNSE)

CIK 1829802 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Faeth Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001727492-26-000018
Aug 14, 2026SCHEDULE 13G/A0001104659-26-096753
Aug 14, 2026SCHEDULE 13G/A0001493152-26-038381
Aug 14, 2026SCHEDULE 13G0001193125-26-352288
Aug 11, 20261440001959173-26-005879
Aug 4, 20268-K0001193125-26-331563
Aug 4, 202610-Q0001193125-26-331562
Jul 28, 202630001193125-26-321026
Jul 23, 202640002111813-26-000012
Jul 23, 202640002038400-26-000004
Jul 23, 20268-K0001193125-26-314591
Jul 1, 202640001780030-26-000006
Jun 26, 202640001780030-26-000005
Jun 24, 202640001780030-26-000004
Jun 24, 202640002111813-26-000010
Jun 23, 202630001780030-26-000003
Jun 23, 2026SCHEDULE 13G0000899140-26-000676
Jun 23, 2026SCHEDULE 13G0001193125-26-279412
Jun 18, 2026S-3ASR0001193125-26-275791
Jun 18, 20268-K0001193125-26-276093
Jun 16, 202640002111813-26-000009
Jun 16, 202640002137706-26-000003
Jun 16, 20264/A0002111813-26-000008
Jun 16, 202640001547959-26-000015
Jun 16, 202630001547959-26-000014